No matches
Type 2 Inflammation

EAACI 2025 | At The Intersection of the Type 2 Airways: Navigating the Challenges of CRSwNP & Co-existing Asthma

Professors Brian Lipworth, Zuzana Diamant, and Philippe Gevaert delve into the complexities of managing patients with both severe and/or uncontrolled CRSwNP and co-existing asthma through an evaluation of the diagnostic challenges, personalized treatment strategies, and the latest advancements in understanding the interconnected pathophysiology of these type 2 airway diseases.
Brian Lipworth
Zuzana Diamant
Philippe Gevaert
MD
Brian Lipworth +2 more

Related resources

Multidisciplinary Partnership for Type 2 Inflammatory Diseases

Multidisciplinary Partnership for Type 2 Inflammatory Diseases

expert video
Role of Type 2 Inflammation in Skin Barrier Dysfunction in AD

Role of Type 2 Inflammation in Skin Barrier Dysfunction in AD

expert video
Role of Type 2 Inflammation Across Different Chronic Diseases

Role of Type 2 Inflammation Across Different Chronic Diseases

expert video
Trajectories of Type 2 Inflammation in Pediatric Patients

Trajectories of Type 2 Inflammation in Pediatric Patients

expert video
Evolving Topics in Type 2 Inflammation

Evolving Topics in Type 2 Inflammation

expert video
Connecting the Dots from Type 2 Inflammation to Patient Perspectives

Connecting the Dots from Type 2 Inflammation to Patient Perspectives

expert video
A Triad of Interacting Mechanisms Driving the Pathophysiology of AD, Asthma, CRSwNP, and EoE

A Triad of Interacting Mechanisms Driving the Pathophysiology of AD, Asthma, CRSwNP, and EoE

Infographic
Managing Type 2 Inflammatory Diseases: Multidisciplinary Frame of Mind

Managing Type 2 Inflammatory Diseases: Multidisciplinary Frame of Mind

expert video
Clinical Manifestations Associated With Airway Remodeling in Asthma

Clinical Manifestations Associated With Airway Remodeling in Asthma

expert video
Impact of Exacerbations in COPD

Impact of Exacerbations in COPD

expert video
Role of Type 2 Cytokines in Asthma and COPD

Role of Type 2 Cytokines in Asthma and COPD

expert video
Exacerbations Lead to Worsening Lung Function

Exacerbations Lead to Worsening Lung Function

expert video
Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma

Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma

expert video
Mucus Plugging as a Potential Target in Asthma Management

Mucus Plugging as a Potential Target in Asthma Management

expert video
Multifaceted Role of IL-13 in Airway Remodeling

Multifaceted Role of IL-13 in Airway Remodeling

expert video
Pediatric Asthma Trajectory and Clinical Remission

Pediatric Asthma Trajectory and Clinical Remission

expert video
2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video

expert video
The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis

The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis

expert video
2025 ADVENT Forum | Potential for Disease Modification in the Airway

2025 ADVENT Forum | Potential for Disease Modification in the Airway

expert video
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners

AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners

videoanimation

Learning objectives

  • Understand the common type 2 pathophysiological mechanisms underlying severe asthma and CRSwNP and the compounded burden of co-existing type 2 inflammatory diseases
  • Highlight available efficacy data in patients with severe/uncontrolled CRSwNP and co-existing asthma from biologic studies
  • Discuss the impact of co-existing type 2 inflammatory diseases on patient burden and management approaches
Tags
coexisting diseasesdisease controlpatient burdenCRSwNPasthma
MAT-GLB-2505375 - 1.0 - 09/2025

About these experts

Allergy/Immunology
MD

Brian Lipworth

Brian Lipworth, MD, is a leading respiratory physician and researcher affiliated with Ninewells Hospital and Medical School, University of Dundee, Scotland, UK. His extensive body of work, reflected in highly cited publications, focuses on asthma and chronic obstructive pulmonary disease (COPD).

Allergy/Immunology
MD, PhD

Zuzana Diamant

Zuzana Diamant is a pulmonologist and clinical pharmacologist. She is currently a Guest Professor at KUL, Leuven, Belgium. Prof. Diamant also holds the position of Research Director Respiratory & Allergy at QPS-Netherlands, Groningen, Netherlands.

Allergy/Immunology
MD, PhD

Philippe Gevaert

Professor of Rhinology and Allergy in the Department of Otorhinolaryngology | Ghent University, Belgium

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: HungaryChange country/region